NCT02460159View on ClinicalTrials.gov

A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384)

PHASE3CompletedINTERVENTIONAL

Enrollment

135

Participants

Timeline

Start Date

June 23, 2015

Primary Completion Date

December 22, 2016

Study Completion Date

December 22, 2016

Conditions

HypercholesterolemiaHeterozygous Familial Hypercholesterolemia

Interventions

DRUG

EZ 10 mg/Atorva 20 mg FDC

DRUG

EZ 10 mg/Atorva 10 mg FDC

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT02460159 - A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384) | Biotech Hunter | Biotech Hunter